Europe GMP Testing Service Market

The Europe GMP testing service market is expected to grow from US$ 616.77 million in 2022 to US$ 897.22 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028.

Expansions Concerning GMP Testing Services Boost Europe GMP Testing Service Market Growth

Many life sciences companies are new to the concept of adopting robotics and cognitive automation (R&CA). The USFDA Regulation 21 requirements have led to uncertainties about R&CA, and their potential impact on human safety has decelerated the progress of the GMP testing industry. Despite the lag in technology adoption, the use of automation is gradually becoming commonplace across pharmaceutical, medical device, and biotechnology companies, especially in various stages of clinical trials and regulatory compliance. Industry 4.0—enabling connectivity, advanced analytics, robotics, and automation—can revolutionize every aspect of pharmaceutical manufacturing in the next 5–10 years. The initial use cases of Industry 4.0 in pharmaceutical manufacturing have been demonstrated to deliver a 30–40% surge in productivity in mature and efficient lab environments; further improvements could lead to more than 50% reductions in the overall quality-control costs. Digitization and automation ensure better quality and compliance by reducing manual errors and variability, simultaneously enabling the faster and more effective addressal of problems. Robotic process automation and cognitive automation, and validation are likely to contribute to the following processes, as a part of GMPs:

Streamlining the tedious product labeling process, supporting advancements in pharmacovigilance by providing tools and ability to process product quality and distribution data

Maintaining official records required by predicate rules that are subject to inspection under FDA requirements, such as study protocols for new drug applications

Enhancing the effectiveness of training and learning management systems (LMS) by automating training assignments, identifying gaps, and facilitating communications with respective personnel

Identifying high-risk abnormalities in images, such as radiology reports, through large-scale interpretation and processing of the data of clinical trials.

Europe GMP Testing Service Market Overview

The Europe GMP testing service market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Rest of Europe consists of countries such as Poland, Austria, Switzerland, Sweden, Norway, Ireland, Denmark, Belgium, and the Netherlands. Europe holds a significant share of the global GMP testing services market and is estimated to record a notable CAGR during the forecast period. The market growth in the region is attributed to the proliferation of the pharmaceuticals, biopharmaceuticals, biotechnology, and medical device industries; product innovations by the market players; and the rising prevalence of chronic diseases.

Europe GMP testing service Market Revenue and Forecast to 2028 (US$ Million)

Europe GMP Testing Service Strategic Insights

Strategic insights for the Europe GMP Testing Service provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe GMP Testing Service Report Scope

Europe GMP Testing Service Regional Insights

The geographic scope of the Europe GMP Testing Service refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe GMP testing service Market Segmentation

The Europe GMP testing service market is segmented on the basis of service type, end user, and country. Based on service type, the Europe GMP testing service market is segmented into product validation testing, bioanalytical services, packaging & shelf-life testing, and other services type. The product validation testing segment held the largest market share in 2022.

Based on end user, the Europe GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies and medical device companies. The pharmaceutical and biopharmaceutical companies segment held a larger market share in 2022.

The Europe GMP testing service market, by country, is segmented into the Germany, the UK, Spain, Italy, France, and Rest of Europe. The Rest of Europe dominated the market share in 2022.

Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; North American Science Associates, Inc.; Nelson Laboratories, LLC.; and Thermo Fisher Scientific Inc. (PPD Inc.) are among the leading companies operating in the Europe GMP testing service market.